Genmab reported 3.19B in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Agios Pharmaceuticals AGIO:US $ 4.3M 1.6M
Amarin AMRN:US $ 143.94M 33.71M
Amgen AMGN:US $ 5327M 250M
Artemis Alpha ATS:LN 2.51M 1.66M
AstraZeneca AZN:LN 9.61B 562M
Bayer BAYN:GR 18.39B 561M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Exelixis EXEL:US $ 235.4M 44.79M
Galapagos GLPG:NA 64.06M 14.46M
Genmab GEN:DC 3.19B 211M
GlaxoSmithKline GSK:LN 6.87B 1.93B
GN Store Nord GN:DC 4.14B 300M
Hikma Pharmaceutical HIK:LN 893M 82M
Insmed INSM:US $ 29.48M 3.76M
Merck MRK:GR € 4867M 162M
Novartis NOVN:VX 8.91B 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Seattle Genetics SGEN:US $ 438.04M 37.03M
William Demant Holding WDH:DC 4.03B 185M